University of California, San Diego-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study

    The Lancet Gastroenterology and Hepatology, Vol. 4, Núm. 12, pp. 960-970